Innate Pharma, Inc

MD · United States · Reporting entity ID 100000791824

Total reported 2019–2025

$3.33M

#850 of 2,960 reporting companies — 0% of all reported industry payments

$72K in general payments across 129 records, plus $3.26M in research funding across 170 records.

How it breaks down

General payments $72,350

Research funding $3,258,304

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.